Home
Archief
SABCS 2023
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 1
Hurvitz Keyslides
O’Shaughnessy Keyslides
Ignatiadis Keyslides
Mamounas Keyslides
Jagsi Keyslides
Highlights Newsletter 2
Podcast with Dr. Sibylle Loibl about the last results of the KATHERINE trial comparing adjuvant ado-trastuzumab emtansine and trastuzumab for the treatment of residual invasive HER2-positive early breast cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Rugo Keyslides
Bardia Keyslides
Waks Keyslides
May Keyslides
Highlights Newsletter 3
Podcast with Prof. Hatem A. Azim about fertility preservation and assisted reproductive technologies in breast cancer patients interrupting endocrine therapy to attempt pregnancy
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Schmid Keyslides
Shimomura Keyslides
Khan Keyslides
Highlights Newsletter 4
Podcast with Prof. Hatem A. Azim about fertility preservation and assisted reproductive technologies in breast cancer patients interrupting endocrine therapy to attempt pregnancy
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Hurvitz Keyslides
Schmid Keyslides
Bardia Keyslides
O’Shaughnessy Keyslides
ESMO 2023
Highlights Newsletter 1
Video with Prof. dr. Patrick Neven about long-term follow-up data of MONARCHE confirm adjuvant abemaciclib plus endocrine therapy as standard of care for patients with high-risk, HR+/HER2- early breast cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Cascone Keyslides
Solomon Keyslides
McCormack Keyslides
Wu Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 2
Girard Keyslides
Albiges Keyslides
Sartor Keyslides
Lisberg Keyslides
Mirza Keyslides
Highlights Newsletter 3
Podcast with Dr. Fatima Cardoso about the results of the phase 3 KEYNOTE-756 trial: Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant endocrine therapy and pembrolizumab in early-stage ER+/HER2- breast cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Kuon Keyslides
Powles Keyslides
Spicer Keyslides
Hadoux Keyslides
Highlights Newsletter 4
Podcast with Dr. Fatima Cardoso about the results of the phase 3 KEYNOTE-756 trial: Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant endocrine therapy and pembrolizumab in early-stage ER+/HER2- breast cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Cascone Keyslides
Sartor Keyslides
McCormack Keyslides
Lisberg Keyslides
WCLC 2023
Highlights Newsletter 1
Podcast with Prof. Natasha Leighl about the use of amivantamab in patients with advanced non-small cell lung cancer and MET Exon 14 skipping mutations
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Thunnissen Keyslides
Yang Keyslides
Zhou Keyslides
Chang Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 2
Lim Keyslides
Cho Keyslides
Waqar Keyslides
Zhou Keyslides
Cheng Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 3
Gadgeel Keyslides
Cho Keyslides
Brandao Keyslides
Peters Keyslides
Janne Keyslides
WCGIC 2023
Highlights Newsletter 1
Podcast with Prof. Bruno Sangro about the four-year overall survival update from the phase III HIMALAYA study
Podcast with Dr. Anna Dorothea Wagner about the integration of trastuzumab, with or without pertuzumab, into perioperative chemotherapy of HER2-positive gastric cancer
Podcast with Dr. Monica Niger about the clinical relevance and actionability of BRAF alterations in advanced biliary tract cancer
Podcast with Marjolein Lansbergen about a transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Li Keyslides
Prager Keyslides
Wyrwicz Keyslides
Lowery Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
ASCO 2023
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 1
Herbst Keyslides
Mellinghoff Keyslides
Choueiri Keyslides
Harter Keyslides
Sonke Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 2
Slamon Keyslides
Tawbi Keyslides
Kudo Keyslides
Meric-Bernstam Keyslides
Chu Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 3
Schrag Keyslides
Monk Keyslides
Ma Keyslides
Fizazi Keyslides
O’Reilly Keyslides
Highlights Newsletter 4
Podcast with Prof. Dr. Lore Decoster about the highlights on lung cancer presented at ASCO 2023
Podcast with Prof. Dr. Hans Prenen about the highlights on gastro-intestinal cancer presented at ASCO 2023
Podcast with Dr. Willem Lybaert about the highlights on head and neck cancer presented at ASCO 2023
Podcast with Prof. Dr. Bart Neyns about the highlights on melanoma presented at ASCO 2023
Podcast with Prof. Dr. Kristof Vulsteke about the highlights on prostate, bladder and kidney cancer presented at ASCO 2023
ELCC 2023
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Girard Keyslides
Rudin Keyslides
Waterhouse Keyslides
Majem Tarruella Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Linardou Keyslide
Garrido Lopez Keyslides
Li Keyslides
Makharadze Keyslides
Highlights Newsletter 3
Podcast with dr. Jordi Remón-Masip about the safety and efficacy of osimertinib versus sequential gefitinib and osimertinib in patients with EGFR-mutant NSCLC
Podcast with Prof. Niels Reinmuth about the patterns of response in metastatic NSCLC after 2 and 4 cycles of chemotherapy, alone or with durvalumab ± tremelimumab
Podcast with Prof. Saadettin Kiliçkap about cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced NSCLC
ASCO GU 2023
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 1
Agarwal Keyslides
Burotto Keyslides
Necchi Keyslides
Hussain Keyslides
Atkins Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 2
Bamias Keyslides
Huddart Keyslides
Clarke Keyslides
Westhofen Keyslides
Highlights Newsletter 3
Podcast with Prof. Daniel Petrylak about pembrolizumab plus docetaxel for patients with metastatic castration-resistant prostate cancer
Podcast with Dr. Matthew D. Galsky about the efficacy and safety of atezolizumab plus platinum/gemcitabine for the first-line treatment of locally advanced or metastatic urothelial carcinoma
Podcast with Dr. Alan H. Bryce about the survival outcomes of rucaparib vs. docetaxel or second-generation androgen pathway inhibitor therapy in mCRPC patients
Podcast with Dr. Vadim Koshkin and Tanya Jindal about biomarkers of response to enfortumab vedotin in advanced urothelial carcinoma
SABCS 2022
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
O’Regan Keyslides
Lu Keyslides
Krop Keyslides
Kaklamani Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Johnston Keyslides
Turner Keyslides
Bidard Keyslides
Kang Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Bardia Keyslides
Partridge Keyslides
Montagna Keyslides
De Censi Keyslides
Highlights Newsletter 4
Podcast with Prof. Sara Hurvitz about treatment with trastuzumab deruxtecan vs. trastuzumab emtansine in HER2-positive metastatic breast cancer: Updated results from DESTINY-Breast03
Podcast with Dr. Judy Boughey about the impact of breast conservation therapy on local recurrence in patients with multiple ipsilateral breast cancer: Results from the Alliance trial
Podcast with Prof. Mafalda Oliveira about different doses of camizestrant monotherapy vs. fulvestrant in advanced ER+/ HER2- breast cancer: Results from SERENA-2
Podcast with Prof. Erica Mayer about fulvestrant, palbociclib, and avelumab treatment combinations for endocrine pre-treated ER+/HER2- metastatic breast cancer: Results from the PACE trial
EBCC 2022
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Hagenaars Keyslides
Kunkler Keyslides
Jhaveri Keyslides
Miglietta Keyslides
ESMO 2022
Highlights Newsletter 1
Podcast with Dr. Laurence Buisseret about first-line chemoimmunotherapy with durvalumab, paclitaxel, and carboplatin with or without the anti-CD73 antibody oleclumab to treat advanced or metastatic triple-negative breast cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Haanen Keyslides
Ray-Coquard Keyslides
Swanton Keyslides
Kasper Keyslides
Highlights Newsletter 2
Podcast with Prof. Richard S. Finn about lenvatinib plus pembrolizumab vs. lenvatinib as first-line therapy for advanced hepatocellular carcinoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Parker Keyslides
Schrag Keyslides
Motzer Keyslides
Dzienis Keyslides
Highlights Newsletter 3
Podcast with Prof. Jean-Pascal Machiels about the primary results of the phase 3 KEYNOTE-412 study: pembrolizumab with chemoradiation vs. placebo plus chemoradiation for locally advanced head and neck squamous cell carcinoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Goetz Keyslides
Kudo Keyslides
Lee Keyslides
Orlandi Keyslides
Highlights Newsletter 4
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 4
Choueiri Keyslides
Johnson Keyslides
Eggermont Keyslides
Kurtz Keyslides
Capdevila Castillon Keyslides
Highlights Newsletter 5
Podcast with Prof. Anne Demols and Prof. Francesco Sclafani about the highlights from ESMO 2022 on gastrointestinal cancer
Podcast with Prof. Christof Vulsteke about the highlights from ESMO 2022 on gynaecological cancer
Podcast with Dr. Willem Lybaert about the highlights from ESMO 2022 on head and neck cancer
Podcast with Prof. Lore Decoster about the highlights from ESMO 2022 on lung cancer
WCLC 2022
Highlights Newsletter 1
Podcast with Prof. Melina Marmarelis about the safety and efficacy of amivantamab and lazertinib in combination with platinum-based chemotherapy in relapsed/refractory EGFR-mutated NSCLC
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Wu Keyslides
Li Keyslides
Provencio Keyslides
Rudin Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 2
Felip Keyslides
Fan Keyslides
Altorki Keyslides
Reck Keyslides
Goldman Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 3
Levy Keyslides
Peeters Keyslides
Thomas Keyslides
Rodriguez-Abreu Keyslides
Murray Keyslides
Highlights Newsletter 4
Podcast with Prof. Johan Vansteenkiste about the challenges and opportunities with immunotherapy in the treatment of patients with squamous cell carcinoma of the lung
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Felip Keyslides
Provencio Keyslides
Li Keyslides
Levy Keyslides
WCGIC 2022
Highlights Newsletter 1
Podcast with Prof. Erika Martinelli about evidence of therapeutic effectiveness of third-line cetuximab rechallenge in appropriately selected patients with metastatic colorectal cancer
Presentation 1
Presentation 2
Presentation 3
Keyslides Newsletter 1
Janjigian Keyslides
Chau Keyslides
Heinemann keyslides
Highlights Newsletter 2
Podcast with Prof. Arndt Vogel about the outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study
Presentation 1
Presentation 2
Presentation 3
Keyslides Newsletter 2
Wang Keyslides
Melero keyslides
Salem Keyslides
Highlights Newsletter 3
Podcast with Dr. Daniele Rossini about modified FOLFOXIRI plus panitumumab (mFOLFOXIRI/PAN) versus mFOLFOX6/PAN as initial treatment of unresectable RAS/BRAF wild-type metastatic colorectal cancer (mCRC) patients (TRIPLETE study)
Presentation 1
Presentation 2
Presentation 3
Keyslides Newsletter 3
Wyrwicz Keyslides
Vogel Keyslides
Yoon Keyslides
Highlights Newsletter 4
Podcast with Prof. Erika Martinelli about evidence of therapeutic effectiveness of third-line cetuximab rechallenge in appropriately selected patients with metastatic colorectal cancer
Presentation 1
Presentation 2
Presentation 3
Keyslides Newsletter 4
Chau Keyslides
Janjigian Keyslides
Wang Keyslides
EADO 2022
Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma
Prof. Nikkels on the TELESPOT project: a Belgian teledermoscopy system in primary healthcare centres for early detection of skin cancer
Prof. Hoeller about the potential role for adjuvant therapy in the treatment of intermediate risk melanoma patients
ASCO 2022
Highlights Newsletter 1
Podcast with Prof. Cornelis J.A. Punt about FOLFOXIRI + bevacizumab vs. FOLFOX/FOLFIRI + bevacizumab in patients with initially unresectable CRLM and right-sided and/or RAS/BRAFV600E-mutated primary tumour
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Spira Keyslides
Motzer Keyslides
Hofman Keyslides
Rugo Keyslides
Highlights Newsletter 2
Podcast with Prof. Christian Blank about personalised response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in resectable stage III melanoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Yoshino Keyslides
Qin Keyslides
Rudin Keyslides
Monk Keyslides
Highlights Newsletter 3
Podcast with Dr. Antonio Avallone and Dr. Alfredo Budillon about randomised intermittent or continuous panitumumab plus FOLFIRI for first-line treatment of patients with RAS/BRAF wild-type metastatic colorectal cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
McCabe Keyslides
Modi Keyslides
Long Keyslides
Noronha Keyslides
Highlights Newsletter 4
Dr. Kevin Punie talks us through some of the key data in the field of breast cancer
Prof. Dr. Hans Prenen shares his highlights in the field of gastro-intestinal cancer
Dr.Willem Lybaert discusses some of the key data in the field of head and neck cancer
Prof. Dr. Lore Decoster will walk us through the highlights in thoracic oncology
Dr. Daan De Maeseneer will share his highlights in the field of urogenital cancer
ELCC 2022
Highlights Newsletter 1
Podcast with Dr. Delvys Rodriguez-Abreu about pembrolizumab plus ipilimumab or placebo in previously untreated metastatic NSCLC with PD-L1 tumor proportion score ≥ 50%: 3-year follow-up of Keynote-598
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Reinmuth Keyslides
Lu Keyslides
Yang Keyslides
Lyu Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 2
Zhou Keyslides
Shi Keyslides
Felip Keyslides
Li Keyslides
Wolf Keyslides
Highlights Newsletter 3
Podcast with Dr. Delvys Rodriguez-Abreu about pembrolizumab plus ipilimumab or placebo in previously untreated metastatic NSCLC with PD-L1 tumor proportion score ≥ 50%: 3-year follow-up of Keynote-598
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Reinmuth Keyslides
Lyu Keyslides
Shi Keyslides
Yang Keyslides
ASCO GU 2022
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 1
Saad Keyslides
Grivas Keyslides
Petrylak Keyslides
Smith Keyslides
Powles Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 2
de Vries Keyslides
Choueiri Keyslides
Loriot Keyslides
Hofman Keyslides
Grimm Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides Newsletter 3
Saad Keyslides
Powles Keyslides
Smith Keyslides
de Vries Keyslides
Loriot Keyslides
ASCO GI 2022
Highlights Newsletter 1
Podcast with dr. Wainberg about the updated results from the phase III Keynote-062 trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Kuang Keyslides
Ikeda Keyslides
Yamaguchi Keyslides
Metges Keyslides
Highlights Newsletter 2
Podcast with dr. Antonio D'Alessio about real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Shitara Keyslides
Hamaguchi Keyslides
Oh Keyslides
Bekaii-Saab Keyslides
Highlights Newsletter 3
Podcast with prof. Romain Cohen about one year of nivolumab plus ipilimumab for MSI/dMMR metastatic colorectal cancer patients
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Yoshino Keyslides
Kato Keyslides
Abou-Alfa Keyslides
André Keyslides
Highlights Newsletter 4
Podcast with dr. Antonio D'Alessio about real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Kato Keyslides
Oh Keyslides
Kuang Keyslides
Yoshino Keyslides
SABCS 2021
Highlights Newsletter 1
PODCAST with Prof. Michael Gnant about adjuvant palbociclib in HR+/HER2- early breast cancer - the final results from the PALLAS trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Goodwin Keyslides
André Keyslides
Xu Keyslides
Bardia Keyslides
Highlights Newsletter 2
Podcast with Prof. Dr. Sara Hurvitz about subgroup analyses from the randomised phase III DESTINY-Breast03 study
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Schmid Keyslides
Bidard Keyslides
Xu Keyslides
Carey Keyslides
Highlights Newsletter 3
Podcast with Dr. Patricia Ganz about the quality of life results from the OlympiA trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Bradley Keyslides
Cortés Keyslides
Krop Keyslides
Jhaveri Keyslides
Highlights Newsletter 4
PODCAST with Prof. Michael Gnant about adjuvant palbociclib in HR+/HER2- early breast cancer - the final results from the PALLAS trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Goodwin Keyslides
André Keyslides
Xu Keyslides
Carey Keyslides
ESMO 2021
Highlights Newsletter 1
Professor Gerhardt Attard - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men with high-risk non-metastatic (M0) prostate cancer (PCa)
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Nishio Keyslides
Cortés Keyslides
Colombo Keyslides
Weiss Keyslides
Highlights Newsletter 2
PODCAST of dr. Robin Cornelissen about efficacy and safety of poziotinib in treatment-naïve NSCLC harboring HER2 exon 20 mutations
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Schmid Keyslides
Janjigian Keyslides
Miura Keyslides
Fizazi Keyslides
Highlights Newsletter 3
PODCAST of prof. dr. Helena Earl about Meta-Analysis of Reduced Duration adjuvant Trastuzumab in the treatment of HER2 positive Early Breast Cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Seligmann Keyslides
Luke Keyslides
Baudin Keyslides
Oosting Keyslides
Highlights Newsletter 4
PODCAST with prof. Eric Pujade-Lauraine about maintenance olaparib rechallenge in patients with ovarian carcinoma previously treated with a PARP inhibitor
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Manich Keyslides
Felip Keyslides
Grohé Keyslides
Brown Keyslides
Highlights Newsletter 5
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 5
Oosting Keyslides
Cortés Keyslides
Schmid Keyslides
Janjigian Keyslides
WCLC 2021
Highlights Newsletter 1
PODCAST with Drs. Daphne Dumoulin, MD about Lurbinectedin in Pre-Treated Patients With Small Cell Lung Cancer and Malignant Pleural Mesothelioma in a Real World Setting
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Smeltzer Keyslides
Bondarenko Keyslides
Chauhan Keyslides
Pastorino Keyslides
Highlights Newsletter 2
PODCAST with Dr. Johnson about Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Gadgeel Keyslides
Huang Keyslides
Spira Keyslides
Carbone Keyslides
Highlights Newsletter 3
PODCAST with Dr. Alexander Spira about Mobocertinib in EGFR Exon 20 Insertion–Positive Metastatic NSCLC Patients With Disease Control on Prior EGFR TKI Therapy
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Evangelist Keyslides
Ramalingam Keyslides
Altorki Keyslides
Camidge Keyslides
Highlights Newsletter 4
PODCAST with Dr. Johnson about Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Evangelist Keyslides
Bondarenko Keyslides
Gadgeel Keyslides
Pastorino Keyslides
WCGIC 2021
Highlights Newsletter 1
Podcast with dr. Zev Wainberg about the preliminary data from a phase 1b trial evaluating the safety and efficacy of tiragolumab combined with atezolizumab for patients with metastatic oesophageal cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Tempero Keyslides
Gkika Keyslides
Taieb Keyslides
André Keyslides
Highlights Newsletter 2
In this podcast, Dr. Lisa Salvatore discusses the primary analysis results of the phase II AVANA study, which evaluated preoperative chemoradiotherapy, combined with avelumab, in patients with locally advanced rectal cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Janjigian Keyslides
Strosberg Keyslides
Shah Keyslides
Abou-Alfa Keyslides
Highlights Newsletter 3
In this podcast, Dr. Zev Wainberg discusses preliminary data from a phase 1b trial evaluating the safety and efficacy of tiragolumab combined with atezolizumab for patients with metastatic oesophageal cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Maio Keyslides
Ducreux Keyslides
Ajani Keyslides
Sunakawa Keyslides
Highlights Newsletter 4
PODCAST with dr. Lisa Salvatore about the primary analysis results of the phase II AVANA study, which evaluated preoperative chemoradiotherapy, combined with avelumab, in patients with locally advanced rectal cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Tempero Keyslides
Shah Keyslides
Ducreux Keyslides
Janjigian Keyslides
ASCO 2021
Highlights Newsletter 1
PODCAST with prof. Thomas Powles about Keynote-426: Pembrolizumab plus axitinib as a first-line treatment option for patients with advanced clear cell renal cell carcinoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Bauml Keyslides
Chau Keyslides
Yuan Keyslides
Xu Keyslides
Highlights Newsletter 2
PODCAST with dr. Josephine Lopes Cardozo: outcomes of patients with an ultralow risk 70-gene signature in the MINDACT trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Dummer Keyslides
Wakelee Keyslides
Mileshkin Keyslides
Morris Keyslides
Highlights Newsletter 3
PODCAST with Prof. Karim Fizazi: first results of the PEACE-1 trial in men with de novo metastatic castration-sensitive prostate cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Perreault Keyslides
Tutt Keyslides
Modest Keyslides
Choueiri Keyslides
Highlights Nieuwsbrief 4
PODCAST with dr. Thierry André about the final overall survival results of the Keynote-177 trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Brose Keyslides
Roth Keyslides
Yoshino Keyslides
Lipson Keyslides
Highlights Newsletter 5
PODCAST with dr. Leisha Emens about the influence of the tumour microenvironment on the clinical outcomes of triple-negative breast cancer patients who are treated with atezolizumab plus nab-paclitaxel
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 5
Roth Keyslides
Yoshino Keyslides
Bauml Keyslides
Tutt Keyslides
ASCO GI 2021
Highlights Newsletter 1
podcast with dr. Kai Keen Shiu about the phase III KEYNOTE-177 study
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Yoshida Keyslides
Koyanagi Keyslides
Tabernero Keyslides
Javle Keyslides
Highlights Newsletter 2
Podcast with dr. Zev Wainberg about the phase II FIGHT study
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Henriksen Keyslides
Boige Keyslides
Zhu Keyslides
Katz Keyslides
Highlights Newsletter 3
Podcast with prof. dr. Eric Van Cutsem about the phase II study evaluating first-line treatments of unresectable mCRC
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Lee Keyslides
Van Cutsem Keyslides
Finn Keyslides
Garcia-Carbonero Keyslides
Highlights Newsletter 4
Podcast with prof.dr. Jean Luc van Laethem about the KEYNOTE 224 trial: phase II study evaluating pembrolizumab monotherapy
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Lee Keyslides
Koyanagi Keyslides
Tabernero Keyslides
Javle Keyslides
ASCO GU 2021
Highlights Newsletter 1
PODCAST with prof. Michael Hofman about the phase II TheraP trial: Lutetium 177 for metastatic castration-resistant prostate cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Joffe keyslides
Balar Keyslides
Motzer Keyslides
Appleman Keyslides
Highlights Newsletter 2
Podcast with prof. Thomas Powles about the EV 301 trial: Phase III study of enfortumab vedotin versus chemotherapy in pre-treated metastatic urothelial carcinoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Rathkopf keyslides
Pal keyslides
De Bono Keyslides
Siva Keyslides
Highlights Newsletter 3
Podcast with prof. Grant Stewart about the NAXIVA trial: a phase II study of neoadjuvant axitinib to reduce venous tumour thrombus in clear cell renal cell carcinoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Ghadjar Keyslides
Choueiri Keyslides
Fizazi Keyslides
Rose Keyslides
Highlights Newsletter 4
Podcast with prof. Thomas Powles about the EV 301 trial: Phase III study of enfortumab vedotin versus chemotherapy in pre-treated locally advanced or metastatic urothelial carcinoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Appleman Keyslides
Rose Keyslides
Rathkopf keyslides
Siva Keyslides
WCLC 2020
Highlights Newsletter 1
Podcast with prof. Michael Boyer about the phase III Keynote 598 study of ipilimumab and pembrolizumab vs. pembrolizumab monotherapy, in metastatic non-small cell lung cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Kilickap Keyslides
Belderbos Keyslides
Cornelissen Keyslides
Spira Keyslides
Highlights Newsletter 2
Podcast with prof. dr. Bob Li about the CodeBreak 100 trial: phase II study of KRAS¬- G12C inhibition with Sotorasib in non-small cell lung cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Wu Keyslides
Zhou Keyslides
Zhao Keyslides
Lee Keyslides
Highlights Newsletter 3
Podcast with dr. Joshua Sabari about the CHRYSALIS study: Phase I trial of amivantamab in non-small cell lung cancer with EGFR exon 20 insertion mutations
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Nakagawa Keyslides
Fennell Keyslides
Novello Keyslides
Reck Keyslides
Highlights Newsletter 4
Podcast with prof. Dean Fennell and prof. Gareth Griffiths about the phase III CONFIRM trial: Nivolumab monotherapy in relapsed mesothelioma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Belderbos Keyslides
Wu Keyslides
Reck Keyslides
Lee Keyslides
ESMO 2020
Highlights Newsletter 1
PODCAST with dr. Mayer about the PALLAS study regarding adjuvant palbociclib for HR+/HER2- early breast cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Tsuboi Keyslides
Choueiri Keyslides
De Bono Keyslides
Miles Keyslides
Highlights Newsletter 2
PODCAST with dr. Eggermont about pembrolizumab after complete resection of high-risk stage III melanoma
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Nakagawa Keyslides
Moehler Keyslides
Johnston Keyslides
Solomon Keyslides
Highlights Newsletter 3
PODCAST with dr. Banerjee about the impact of COVID-19 on oncology professionals
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Le Pechoux Keyslides
Kato Keyslides
Tran Keyslides
Colombo Keyslides
Highlights Newsletter 4
PODCAST with dr. Bardia about the ASCENT study examining sacituzumab govitecan in metastatic triple-negative breast cancer
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Tsuboi Keyslides
Choueiri Keyslides
Moehler Keyslides
Le Pechoux Keyslides
WCGIC 2020
Highlights Newsletter 1
PODCAST with prof. Bruno Sangro about the CheckMate 459 trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Ramaswamy Keyslides
Wainberg Keyslides
Yamaguchi Keyslides
Grothey Keyslides
Highlights Newsletter 2
Podcast with dr. Manish R. Patel about the efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Li Keyslides
Rovers Keyslides
Sunakawa Keyslides
Yoon Keyslides
Highlights Newsletter 3
Podcast with dr. Manish R. Patel about the efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers
Presentation 2
Presentation 1
Presentation 3
Presentation 4
Keyslides Newsletter 3
Li Keyslides
Yamaguchi Keyslides
Ramaswamy Keyslides
Rovers Keyslides
ASCO 2020
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
PODCAST Javier Cortes about the KEYNOTE-355 trial
Keyslides Newsletter 1
Warner Keyslides
André Keyslides
Fares Keyslides
Poveda Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
PODCAST Nadia Harbeck about the KAITLIN study
Keyslides Newsletter 2
Powles Keyslides
Motzer Keyslides
Lorenzen Keyslides
Gogas Keyslides
Highlights Newsletter 3
PODCAST: Egbert Smit about the DESTINY-Lung01 trial
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Conroy Keyslides
Mirza Keyslides
Cardoso Keyslides
Li Keyslides
Highlights Newsletter 4
PODCAST Maha Hussain about the IMvigor010 study
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Herbst Keyslides
Lin Keyslides
Hauschild Keyslides
Fizazi Keyslides
Highlights Newsletter 5
PODCAST Luis Paz-Ares about the CASPIAN study
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 5
Cardoso Keyslides
Warner Keyslides
Mirza Keyslides
André Keyslides
ESMO 2019
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. Patrick Neven
Keyslides Newsletter 1
Ray-Coquard Keyslides
Smith Keyslides
Yau Keyslides
Larkin Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with prof. Laura Q.M. Chow
Keyslides Newsletter 2
Sledge Keyslides
González-Martín Keyslides
Ramalingam Keyslides
Hussain Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. Noel Clarke
Keyslides Newsletter 3
Tabernero Keyslides
Peters Keyslides
Schmid Keyslides
De Wit Keyslides
Highlights Newsletter 4
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. Jean-Pascal Machiels
Keyslides Newsletter 4
Sledge Keyslides
Peters Keyslides
Hussain Keyslides
Ray-Coquard Keyslides
ASCO 2019
Highlights Newsletter 1
Video interview with Josep Tabernero
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Garon Keyslides
Guigay Keyslides
Sastre Keyslides
Chi Keyslides
Highlights Newsletter 2
Video interview with Daniel P. Petrylak
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Tap Keyslides
Hurvitz Keyslides
Cascone Keyslides
Liszkay Keyslides
Highlights Newsletter 3
Video interview with Sara Hurvitz
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Sweeney Keyslides
Penson Keyslides
Nakagawa Keyslides
Tempero Keyslides
Highlights Newsletter 4
Video interview with Hedy Kindler
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Guigay Keyslides
Sweeney Keyslides
Nakagawa Keyslides
Tap Keyslides
ASCO 2018
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Robert M. Jotte
Keyslides Newsletter 1
Earl Keyslides
Stadler Keyslides
Tsimberidou Keyslides
Baselga Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Arnoud Méjean
Keyslides Newsletter 2
Slamon Keyslides
Bisogno Keyslides
Lopes Keyslides
Conroy Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Geertjan van Tienhoven
Keyslides Newsletter 3
Borgheai Keyslides
Sparano Keyslides
Quenet Keyslides
Weber Keyslides
Highlights Newsletter 4
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Patrick Neven
Keyslides Newsletter 4
Sparano Keyslides
Conroy Keyslides
Stadler Keyslides
Bisogno Keyslides
ESMO 2018
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Peter Schmid
Keyslides Newsletter 1
Smith Keyslides
André Keyslides
Papadimitrakopoulou Keyslides
Rini Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Jonathan Ledermann
Keyslides Newsletter 2
Cristofanilli Keyslides
Parker Keyslides
Sakai Keyslides
Mehanna Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. John Haanen
Keyslides Newsletter 3
Wu Keyslides
Lenz Keyslides
Burtness Keyslides
Arkenau Keyslides
Highlights Newsletter 4
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. Jonathan Ledermann
Keyslides Newsletter 4
Lenz Keyslides
Cristofanilli Keyslides
Parker Keyslides
Mehanna Keyslides
ESMO 2017
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. Corey Langer
Keyslides Newsletter 1
Sydes Keyslides
Saura Keyslides
Wainberg Keyslides
Paz-Ares Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. Bernard Escudier
Keyslides Newsletter 2
Westeel Keyslides
Voest Keyslides
Di Leo Keyslides
Weber Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Prof. Daniel Petrylak
Keyslides Newsletter 3
De Wit keyslides
Ramalingam Keyslides
Gupta Keyslides
Hauschild Keyslides
ASCO 2017
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video-interview with Prof. Dr. Nicholas James
Keyslides Newsletter 1
Primrose Keyslides
Hoskins Keyslides
Wu Keyslides
Tredan Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video-interview with Prof. Dr. Günter von Minckwitz
Keyslides Newsletter 2
Grothey Keyslides
Fizazi Keyslides
Mok Keyslides
Lambertini Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video-interview with Prof. Ronald de wit
Keyslides Newsletter 3
Shaw Keyslides
Robson Keyslides
Scherpereel Keyslides
Basch Keyslides
Smith Keyslides
ESMO 2016
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with prof. dr. E. Van Cutsem
Keyslides Newsletter 1
Mirza Keyslides
Ellis Keyslides
Barlesi Keyslides
Robert Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Interview with professor B. Neyns
Keyslides Newsletter 2
Fizazi keyslides
Choueiri Keyslides
Langer Keyslides
Gronchi Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Interview with professor H. Wildiers
Keyslides Newsletter 3
Reck Keyslides
Ravaud Keyslides
Scagliotti Keyslides
Harrington Keyslides
SABCS 2016
Highlights newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Interview with Prof. Dr. Hans Wildiers
Keyslides Newsletter 1
Rimawi Keyslides
Robertson Keyslides
Bourdeanu Keyslides
Kornblum Keyslides
Han Keyslides
Highlights newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video interview with Prof. Wiebren Tjalma
Keyslides Newsletter 2
Bachelot Keyslides
DiLeo Keyslides
Classe Keyslides
Steger Keyslides
Brufsky Keyslides
Highlights newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video interview with Prof. Dr. Veronique Cocquyt
Keyslides newsletter 3
Swain Keyslides
Karakatsanis Keyslides
Yardley Keyslides
Dalmasso Keyslides
De Azambuja Keyslides
Highlights Newsletter 4
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Interview with Prof. Ruth O'Ryan
Keyslides Newsletter 4
Cocquyt Keyslides
Classe Keyslides
Han Keyslides
Dalmasso Keyslides
Robertson Keyslides
ECC 2015
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with professor J. O'Sullivan
Keyslides Newsletter 1
Sharma Keyslides
Lambertini Keyslides
Pietanza Keyslides
Robert Keyslides
Video interview with professor J. O'Sullivan
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Video interview with Professor E. van Cutsem
Keyslides Newsletter 2
Choueiri Keyslides
Larkin Keyslides
Horn Keyslides
Ruszniewski Keyslides
Video interview with Professor E. van Cutsem
ESMO 2014
Highlights newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video-interview with Prof. Hans Wildiers
Keyslides newsletter 1
Temel keyslides
Ahn keyslides
Machiels keyslides
Symonds Keyslides
Amant keyslides
Highlights newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video-interview with Didier Verhoeven
Keyslides newsletter 2
Kim keyslides
Ryan Keyslides
Goss Keyslides
Fasching Keyslides
Weber Keyslides
Highlights newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video interview with Paul Germonpré
Keyslides newsletter 3
Gligorov Keyslides
Lenz Keyslides
Mok Keyslides
McArthur Keyslides
Zhu Keyslides
Highlights newsletter 4
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video interview with Prof. Ahmad Awada
Keyslides newsletter 4
Vansteenkiste Keyslides
Robert Keyslides
Chasen Keyslides
Von Minckwitz Keyslides
Stahel Keyslides
Highlights newsletter 5
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Video interview with Prof. Philippe Collard
Keyslides newsletter 5
Gligorov Keyslides
Lenz Keyslides
Goss Keyslides
Fasching Keyslides
Symonds Keyslides
ESMO 2012
Highlights newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides newsletter 1
Zielinski Keyslides
Pivot Keyslides
Verma Keyslides
Qi Keyslides
Highlights newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides newsletter 2
Pivot Keyslides
Gelber Keyslides
Arnedos Keyslides
Beauchemin Keyslides
SABCS 2012
Highlights newsletter 1
Presentation 1
Presentation 2
Presentation 3
Keyslides newsletter 1
Martin Keyslides
Sgroi Keyslides
Yarnold Keyslides
Highlights newsletter 2
Presentation 1
Presentation 2
Presentation 3
Keyslides newsletter 2
Cameron Keyslides
Kaufman Keyslides
Finn Keyslides
EBCC 2012
Highlights newsletter 1
Presentation 1
Presentation 2
Presentation 3
Keyslides newsletter 1
Donker Keyslides
Gnant Keyslides
Linn Keyslides
Highlights newsletter 2
Presentation 1
Presentation 2
Presentation 3
Keyslides newsletter 2
Krekel Keyslides
Ligibel Keyslides
Vulsteke Keyslides
SABCS 2011
Highlights newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Keyslides newsletter 1
Gnant Keyslides
Galimberti Keyslides
Paterson Keyslides
Hortobagyi Keyslides
Liu Keyslides
Highlights newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Presentation 5
Presentation 6
Keyslides newsletter 2
Gianni Keyslides
Van den Broek Keyslides
Baselga Keyslides
De Boer Keyslides
Solin Keyslides
ASCO GU 2024
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Agarwal Keyslides
Young Keyslides
Powles Keyslides
Aggen Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Apolo Keyslides
Hassoun Keyslides
Hennequin Keyslides
George Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Cigliola Keyslides
Choueiri Keyslides
Van der Heijden Keyslides
Ben-David Keyslides
ASCO 2024
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Solomon Keyslides
Hoeppner Keyslides
Blank Keyslides
Gootjes Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Classe Keyslides
Mok Keyslides
Ramalingam Keyslides
Curigliano Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Spigel Keyslides
Galle Keyslides
Fizazi Keyslides
Kalinsky Keyslides
Highlights Newsletter 4
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 4
Conte Keyslides
Pietrantonio Keyslides
Paz-Ares Keyslides
Popat Keyslides
WCGIC 2024
Highlights Newsletter 1
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 1
Gelli Keyslides
Ducreux Keyslides
Shitara Keyslides
Singh Keyslides
Highlights Newsletter 2
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 2
Randon Keyslides
Sclafani Keyslides
Lonardi Keyslides
Tougeron Keyslides
Highlights Newsletter 3
Presentation 1
Presentation 2
Presentation 3
Presentation 4
Keyslides Newsletter 3
Randon Keyslides
Gelli Keyslides
Tougeron Keyslides
Singh Keyslides
Search
Solomon Keyslides
Speaker Ben Solomon
Ben Solomon, MD, PhD, Peter MacCallum Cancer Centre, Melbourne, Australia
See:
Presentation
Back to Top